ext_206294 (
alwaysamommy.livejournal.com) wrote in
vaginapagina2007-08-12 12:25 pm
![[identity profile]](https://www.dreamwidth.org/img/silk/identity/openid.png)
![[community profile]](https://www.dreamwidth.org/img/silk/identity/community.png)
Entry tags:
Herpes in Gay couples
This doesn't actually apply to me but I was curious. Last night, I was watching the commercial for Valtrex. At the bottom of the screen, a disclaimer flashed saying that Valtrex has only been tested in heterosexual couples. Honestly, I can't see a difference. It's not like a virus such as Herpes is going to care if you're male or female, right?
I was just curious what any potential difference would be.
I was just curious what any potential difference would be.
no subject
no subject
no subject
no subject
We probably have that idea that heterosexual sex=PIV because it actually is most common practise for heterosexual couples. Therefore, the subjects in Valtrex's studies might have had anal intercourse a few times and might not have had much, if any, PIV. Female partners might have been strapping on, and partners might have been having a mainly manual sex. But, for whatever reason, we view those as "alternative" behaviours ("if there's no penis in your relationship, you can use a dildo or your hands. If there's no vagina in your relationship, you can penetrate an anus.") rather than standard ones, and assume that if there is a penis and a vagina in a sexual relationship, they'll tend to find one another.
Fair and truthful? Not really. But I think that it might still be safe to guess that most of those partners were engaged mainly in oral sex and PIV for most of their sexual activity.
It'd be pretty interesting to learn if Valtrex actually collected information on the type of sex that participants in the study were having.
Also, looking at the Valtrex website, it appears that their research studies were "randomized, double-blind, placebo-controlled, multicenter trial[s] of 1484 immunocompetent, heterosexual, monogamous couples discordant for HSV-2". In other words, their official trials used specifically (currently) exclusively heterosexual couples, and therefore they may not be allowed by the FDA to extrapolate that data.
This probably also be a deliberate move on Valtrex's part to extend their patent on the for Valtrex. If a drug company can prove that a drug has other uses (first it can protect people having heterosexual sex, and in three years they announce that studies have shown that it can protect men having anal intercourse), they can renew their patent and stave off generics for another few years, so they keep receiving the sales.
I've thought wayyy too much about this.
no subject
no subject
no subject
Just the rules of research.
no subject